← Back to Search

Group Fitness for Schizophrenia

N/A
Waitlist Available
Led By Hannah Brown, MD
Research Sponsored by Boston Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 22 weeks
Awards & highlights
No Placebo-Only Group

Study Summary

This trial will test a new intervention for people with schizophrenia that includes group fitness and nutrition education delivered remotely.

Eligible Conditions
  • Schizophrenia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~22 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 22 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Feasibility of lifestyle intervention
Tolerability of educational nutritional sessions
Tolerability of group fitness classes
Secondary outcome measures
Change in Hemoglobin A1c level (HbA1c)
Change in nutritional knowledge
Change in physical activity level
+6 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Group A- Intervention/Non-InterventionExperimental Treatment2 Interventions
Participants in this arm will initially be randomized to the intervention period and will receive the interventions for 11 weeks followed by no interventions for 11 weeks.
Group II: Group B- Non-Intervention/InterventionActive Control2 Interventions
Participants in this arm will initially be randomized to the non-intervention period for 11 weeks followed by the intervention period for 11 weeks.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Group Fitness
2021
N/A
~460

Find a Location

Who is running the clinical trial?

Boston Medical CenterLead Sponsor
382 Previous Clinical Trials
869,523 Total Patients Enrolled
1 Trials studying Schizophrenia
350 Patients Enrolled for Schizophrenia
Hannah Brown, MDPrincipal InvestigatorBoston Medical Center

Media Library

Schizophrenia Research Study Groups: Group A- Intervention/Non-Intervention, Group B- Non-Intervention/Intervention

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants have volunteered for this research endeavor?

"Affirmative, the information on clinicaltrials.gov indicates that this medical trial is accepting enrolment applications. The study was publicized on October 26th 2021 and recently updated June 24th 2022; it targets to recruit a total of 24 patients from 2 participating locations."

Answered by AI

Is the enrollment process for this investigation still ongoing?

"Affirmative. According to clinicaltrials.gov, this trial is actively recruiting and was initially posted on October 26th 2021 with a recent update of June 24th 2022. The study requires the participation of 24 patients across 2 sites."

Answered by AI

What benefits are anticipated from this trial's results?

"This trial's primary outcome, which will be assessed over the course of 22 weeks, is the tolerability of educational nutritional sessions. Secondary outcomes include an assessment of psychological well-being through a Personal Health Questionnaire-9 (PHQ-9), change in weight which participants are asked to self report and share with research assistants on phone calls, as well as changes in self esteem measured by scores from a 12-item Short Form Health Survey (12 SFHS) and State Self Esteem Scale (SSES). Scores for these assessments range between 1 - 27 for PHQ- 9 and 20 - 100 for SSES respectively."

Answered by AI
~6 spots leftby Feb 2025